USANA Health Sciences (USNA) Tops Q1 EPS by 17c ; Offers Guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $15.20 +1.60%
Revenue Growth %: +5.0%
Financial Fact:
Other income (expense), net: 268K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.0%
Financial Fact:
Other income (expense), net: 268K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q1 EPS of $0.86, $0.17 better than the analyst estimate of $0.69. Revenue for the quarter came in at $228 million versus the consensus estimate of $226.84 million.
GUIDANCE:
USANA Health Sciences sees FY2024 EPS of $2.40-$3.00, versus the consensus of $2.73. USANA Health Sciences sees FY2024 revenue of $850-920 million, versus the consensus of $889.8 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Braze stock tumbles 10% on weak third quarter EPS guidance
- GameStop beats second quarter estimates on collectibles
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
